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Summary
ING2 (inhibitor of growth protein-2) is a member of the ING-gene family and participates in
diverse cellular processes involving tumor suppression, DNA repair, cell cycle regulation, and cellular
senescence. As a subunit of the Sin3 histone deacetylase complex co-repressor complex, ING2 binds to
H3K4me3 to regulate chromatin modification and gene expression. Additionally, ING2 recruits histone
methyltransferase (HMT) activity for gene repression, which is independent of the HDAC class I or II
pathway. However, the physiological function of ING2 in mouse preimplantation embryo development
has not yet been characterized previously. The expression, localization and function of ING2 during
preimplantation development were investigated in this study. We showed increasing expression of ING2
within the nucleus from the 4-cell embryo stage onwards; and that down-regulation of ING2 expression
by endoribonuclease-prepared small interfering RNA (esiRNA) microinjection results in developmental
arrest during the morula to blastocyst transition. Embryonic cells microinjected with ING2-specific
esiRNA exhibited decreased blastulation rate compared to the negative control. Further investigation of
the underlying mechanism indicated that down-regulation of ING2 significantly increased expression
of p21, whilst decreasing expression of HDAC1. These results suggest that ING2 may play a crucial role
in the process of preimplantation embryo development through chromatin regulation.
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Introduction
Preimplantation embryo development includes fertil-
ization, cell cleavage, morula and blastocyst form-
ation. The formation of a healthy blastocyst is
critical for subsequent implantation, pregnancy and
fetal development (Watson & Barcroft, 2001). The
preimplantation embryo exhibits an autonomous
development capability influenced by various factors
within the maternal and embryonic environment
(Schultz, 2005). Similarly, in vitro culture conditions
also exert crucial effects on embryo developmental
potential (Niemann & Wrenzycki, 2000; Schultz &
Williams, 2002; Ecker et al., 2004). In clinical assisted
reproductive technology, embryos are selected for
transfer based mainly on morphological criteria, which
to some extent reflect their developmental potential.
In most cases, day-2 or day-3 cleavage-stage embryos
are usually transferred. Human embryonic genome
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activation (EGA) occurs from the 4–8-cell stage
(Braude et al., 1988), which makes embryo selection
at earlier developmental stages less reliable. In reality,
prolonged culture is not always utilized as a selection
tool because aneuploidies or aberrant gene expression
prevent development to the blastocyst stage in a
large proportion of embryos (Gardner et al., 1998; Dal
Canto et al., 2012). Hence, it is imperative to char-
acterize the mechanisms controlling preimplantation
development, to further our understanding of basic
reproductive biology, as well as advance practical
applications in the clinic.
Preimplantation embryonic development is regu-
lated both genetically and epigenetically. The global
gene expression profile is dynamic and displays
stage-specific characteristics at different develop-
mental stages of the preimplantation embryo. For
example, Oct4, Nanog, Gata3 and Bmp8b are activated
between the 4–8-cell embryonic stage (Hamatani
et al., 2004). These genes are key regulators of
differentiation into the inner cell mass (ICM) and
trophectoderm (TE), which is the very first cell
lineage specification in mouse embryonic develop-
ment (Yamanaka et al., 2006). Many studies have
suggested that DNA methylation and the regulation
of histone modifications have profound effects on
preimplantation embryonic development (Monk et al.,
1987; Santos et al., 2005; Yeo et al., 2005; Torres-
Padilla et al., 2006). Two major histone deacetylase
(HDAC) complexes (NuRD and SIN3) have specific
functions in embryonic development (Ahringer, 2000).
HDAC1 is a major deacetylase in preimplantation
embryos and its expression negatively regulates the
acetylation state of histone H4K5 during preim-
plantation embryonic development (Ma & Schultz,
2008). Although knowledge of the mechanisms of
preimplantation development has increased gradually
over the past decade, the key transcription factors
that are essential for blastocyst formation and how
they interact with epigenetic regulators have yet to be
characterized.
ING2 participates in diverse cellular processes
involving tumor suppression, DNA repair, cell cycle
regulation, and cellular senescence, all of which are
functionally linked to the p53 tumor suppressor pro-
tein (Unoki et al., 2008; Zhang et al., 2008; Larrieu et al.,
2009). Additionally, ING2 has biological functions
that are independent of the p53 pathway. As a basic
subunit of the histone deacetylase Sin3 complex, ING2
mediates the binding of the Sin3 complex to some
promoters where di-/tri-methylated H3K4 regulates
gene repression (Smith et al., 2010). ING2 can also
play a role in modulating histone methyltransferase
(HMT) activity associated with silencing function,
which involves a non-HDAC class I or II pathway
(Goeman et al., 2008). As ING2 modulates both gene
expression and chromatin modification, this study
attempted to examine the role of ING2 in mouse
preimplantation embryonic development.
Materials and methods
All chemicals and culture media were purchased from
Sigma-Aldrich Inc. (St. Louis, MO, USA), unless stated
otherwise.
Embryo collection and culture
The ICR mice were fed ad libitum with a standard
diet and were housed in a room with controlled
temperature and lighting (20–22°C, 12 h/12 h
light/dark cycle), in accordance with the Institutional
Animal Care and Use Committee (IACUC) guidelines
of Nanjing Medical University. For the collection of
zygotes, 8-week-old female ICR mice were injected
with human chorionic gonadotropin (HCG) and mated
with male ICR mice shortly after injection. After 21 h,
zygotes were collected from the oviducts of the mated
female mice and transferred into 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES)-buffered
Chatot, Ziomet and Bavister (CZB) medium. Cumulus
cells were dispersed by treatment with 1 mg/ml
hyaluronidase in HEPES-CZB. Cumulus-free zygotes
were washed with HEPES-CZB medium and then
cultured in CZB medium until they developed to later
cleavage-stage embryos. All cultures were carried out
within a humidified 5% CO2 incubator at 37°C.
Immunofluorescence and confocal microscopy
For immunofluorescence staining of ING2, the
embryos were fixed in 4% paraformaldehyde in
phosphate-buffered saline (PBS; pH 7.4) for at least 30
min at room temperature. After being permeabilized
with 0.5% Triton X-100 at room temperature for 20
min, the embryos were incubated for 1 h in blocking
solution composed of 1% bovine serum albumin in
PBS, followed by incubation with goat anti-ING2
antibody (dilution, 1:100) overnight at 4°C. After
three washes in PBS containing 0.1% Tween 20 and
0.01% Triton X-100 for 5 min each, the embryos were
labelled with fluorescein isothiocyanate-conjugated
rabbit anti-goat IgG (dilution, 1:100) for 1 h at room
temperature. After three washes in PBS containing
0.1% Tween 20 and 0.01% Triton X-100, the embryos
were co-stained with propidium iodide (10 g/ml
in PBS), prior to being mounted on glass slides and
examined under a confocal laser scanning microscope
(Zeiss LSM 510 META, Jena Germany).
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Immunoblotting analysis
The extracted proteins of adult ICR mouse ovaries
and morphologically normal 4-cell embryos (150
embryos/sample) were separated by sodium
dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) and then subsequently transferred
to polyvinylidene fluoride membranes via
electrophoresis. Following the transfer, the membranes
were blocked in TBST (TBS buffer with 0.1% Tween
20) containing 5% skimmed milk for 2 h, followed
by incubation overnight at 4°C with goat polyclonal
anti-ING2 antibody (dilution, 1:500; sc-67646, Santa
Cruz, Dallas, TX, USA). After being washed in TBST
three times for 10 min each, the membranes were
incubated for 1 h at 37°C with horseradish peroxidase-
conjugated rabbit anti-goat IgG (dilution, 1:1000).
Finally, the membranes were processed and analyzed
using an enhanced chemiluminescence detection
system (Amersham, Piscataway, NJ, USA).
Reverse transcription polymerase chain reaction
(RT-PCR)
The primer sequences utilized for RT-PCR ana-
lysis of Ing2 expression were as follows: sense,
5′-GGGAGCTGGACAACACCTACCAA-3′ and anti-
sense, 5′-TTCGAGCATCTGGGTGACAATC-3′. Total
RNA extraction and RT were performed using an
RNeasy Micro Kit (Qiagen, Valencia, CA, USA), ac-
cording to the manufacturer’s instructions; with oligo-
dT being utilized as a primer. Real-time PCR analysis
was carried out using a Faststart Universal SYBR
Green Master Mix (no. 04913914001, Roche Inc., Basel,
Switzerland), with an ABI Prism 7500 System (Applied
Biosystems, Foster City, CA, USA). We processed 15–
30 embryos at a time, and the H3f3a gene was utilized
as an endogenous control (May et al., 2009). Relative
quantitation of target gene expression was evaluated
by the 2−Ct method (Livak & Schmittgen, 2001) and
data were collated from three replicate experiments
utilizing different sets of embryos.
ING2 MISSIONR© esiRNA and in vitro culture
ING2 MISSION R© esiRNA (EMU022101) and negative
control EGFP MISSION R© esiRNA (EHUEGFP) were
purchased from Sigma-Aldrich Inc. (St. Louis, MO,
USA), which possessed the intellectual property to
design and prepare the MISSION esiRNA. The Ing2














AGATGATAGGCTG-3′. MISSION esiRNA are a
heterogeneous mixture of siRNAs that all target the
same mRNA sequence. These multiple silencing
triggers lead to lower off-target effects than single or
pooled siRNAs, and exert highly specific and effective
gene silencing. The concentration of ING2 MISSION
esiRNA was 200 ng/l in nuclease-free TE buffer (10
mM Tris-HCl, pH 8.0, 1 mM EDTA). Approximately
10 pl of individual esiRNA was microinjected into the
cytoplasm of the zygotes, which were cultured in CZB
medium and subjected to further observation. The
developmental progress of each group was observed
and analyzed using a Nikon TE2000-S microscope.
Statistical analysis
Each experiment was repeated at least three times.
Before statistical analysis, all percentage data were
subjected to arc-sine transformation. Data were
analyzed with one-way analysis of variance, paired
Student’s t-test and the chi-squared test, using SPSS
software (SPSS Inc., Chicago, IL). Data are expressed
as mean ± standard deviation (SD), with a P-value <
0.05 being considered statistically significant.
Results
The expression of ING2 during mouse
preimplantation development
We analyzed the expression profile of Ing2 at
each stage of mouse preimplantation embryonic
development. The RT-PCR data confirmed expression
of Ing2 in mouse preimplantation embryos (Fig. 1A),
and further analysis revealed variation in expression
levels of Ing2 at different embryonic developmental
stages (Fig. 1B). Most notably, Ing2 expression rapidly
increased from the 2-cell to 4-cell cleavage-stage. This
suggests that Ing2 may be a crucial modulator of early
embryonic development genes. Western blot analysis
utilizing an anti-ING2 antibody revealed an exclusive
band at the expected molecular mass of 33 kDa, for
both the mouse ovary and 4-cell embryo (Fig. 2A).
The localization of ING2 during mouse
preimplantation development
Laser scanning confocal microscope was used to
analyze subcellular localization of ING2 protein at
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Figure 1 (A) SDS-PAGE gel of RT-PCR amplification of Ing2 mRNA transcripts extracted at different embryonic stages. H3f3a
was utilized as the endogenous reference gene. Lanes 1, 2, 3, 4, 5 corresponds to zygote, 2-cell embryo, 4-cell embryo, morula-
stage embryo and blastocyst-stage embryo respectively. (B) Real-time PCR analysis of Ing2 mRNA expression patterns at
different embryonic stages during mouse preimplantation development. The expression level was calculated from the cycle
threshold (Ct) values by the 2−Ct method. The calibration sample was embryos at the zygote stage. Bar graphs indicate mean
± standard deviation (SD) of three experimental replicates.
different stages of the mouse preimplantation embryo.
There was increased expression of ING2 from the 2-cell
embryo stage onwards with increasing accumulation
within the nucleus beginning from the 4-cell embryo
stage (Fig. 2B). Unstained 2-cell embryos were utilized
as the negative controls (Fig. 2C). The immunostaining
result is consistent with the mRNA expression patterns
revealed by RT-PCR. ING2 C-terminal contains a
nuclear localization sequence (NLS) domain, which
possesses three nuclear targeting sequences (NTS)
that target to the nucleolus. Hence, the nuclear
localization of ING2 thus suggests that ING2 may
have key functions in regulating gene transcription or
chromosome modification.
Knockdown of ING2 retards embryonic
development in vitro
To investigate the role of ING2 in mouse embryos,
zygotes were microinjected with sigma MISSION
esiRNA against ING2. Zygotes microinjected with
sigma negative MISSION esiRNA served as controls.
Real-time PCR showed that the expression level
of ING2 was significantly reduced (Fig. 3A) upon
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Table 1 The developmental competence of embryos that were microinjected with
ING2-specific esiRNA or negative esiRNA was evaluated by determining the ratios of
microinjected embryos progressing to various developmental stages
No. of embryos (%)
Treatment Total 4-cell Morula Blastocyst
Ing2-esiRNA 150 124 (82.7) 101 (67.3) 73 (48.7)
Control 132 125 (94.7)∗∗ 118 (89.4)∗∗ 100 (75.8)∗∗
∗∗ Values were considered significantly different from the control at P < 0.01 (vs. control).
Figure 2 (A) Western blot with the anti–ING2 antibody showed only one distinct band at the predicted molecular weight
of ING2 protein (33 kD), for both the mouse ovary and 4-cell embryo. (B) Immunofluorescence staining of ING2 and nuclear
DNA in preimplantation embryos with specific anti-ING2 antibody (green, a′–f′) and propidium iodide (red, a′ ′–f′ ′) respectively.
zygote, approximately 21 h after human chorionic gonadotropin (HCG) injection (a′, a′ ′); 2-cell embryo, approximately 45 h
after HCG injection (b′, b′ ′); 4- to 8-cell embryo, approximately 58 h after HCG injection (c′, c′ ′, d′, d′ ′); morula, approximately
78 h after HCG injection (e,′ e′ ′) and blastocyst, approximately 96 h after HCG injection (f′, f′ ′). Scale bar: 2 m. (C) Unstained
2-cell embryo was utilized as the negative control. Scale bar: 1 m.
microinjection with the esiRNA, and this was further
confirmed by reduced expression at the protein level
detected by immunostaining (Fig. 3B). Inverted light
microscopy was used to track the development of
the treated embryos that were cultured up to the
blastocyst stage (Fig. 3C). Notably, statistical analysis
showed significant differences in the ratio of embryos
that developed to the 4-cell, morula and blastocyst
stage between the treated group (n = 150) and the
negative control group (n = 132): 82.7% vs. 94.7% (P
< 0.05), 67.3% vs. 89.4% (P < 0.05), 48.7% vs. 75.8%
(P < 0.01) (Table 1). This demonstrated that ING2
expression was essential to mouse preimplantation
embryonic development.
RNAi-mediated ablation of Ing2 results in increased
p21 and decreased HDAC1 expression
To gain a better understanding of the basis for the
developmental delay of the Ing2-depleted embryos, we
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Figure 3 Zygotes were microinjected with ING2 specific sigma MISSION esiRNA. (A) Real-time PCR detected down-
regulation of Ing2 expression. The control and calibration sample was untreated zygotes. Error bars represent standard
deviation (SD) (∗P < 0.05). (B) Immunofluorescence staining confirmed decreased ING2 protein expression levels in the
microinjected mouse embryos. (C) After zygotes were microinjected with ING2 specific esiRNA, the ratio of embryos that
progressed to later embryonic developmental stages was evaluated. The depletion of ING2 led to developmental retardation.
The results of five independent experiments were collated (∗P < 0.05, ∗∗P < 0.01).
Figure 4 Real-time PCR analysis of expression of Ing2-associated genes in early blastocyst stage embryos after microinjection
with ING2 specific esiRNA. The control and calibration sample was untreated embryos at the same developmental stage
(early blastocyst). Data are presented as the mean of at least three biological replicates. Bar graphs indicate mean ± standard
deviation (SD); ∗P < 0.05 vs. control.
assayed expression of p21, Bax, and HDAC1 in these
embryos by real-time PCR. The rationale for doing so
is that ING2 activation leads to up-regulation of p21
and Bax in a number of cancer cell lines (Nagashima
et al., 2001). Additionally, HDAC inhibitors have been
shown to induce expression of p21 in many cell types
and tumors, leading to cell cycle arrest (Zhu et al.,
2004). Induction of p21 was also observed in Hdac1-
deficient embryonic stem cells (Lagger et al., 2002).
In this study, we observed a 2.3-fold increase in p21
mRNA expression level at the early blastocyst stage (96
h post-hCG injection), while there was a corresponding
85% decrease in HDAC1 mRNA level at the same
time point in Ing2-depleted embryos (Fig. 4). It is
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hypothesized that the ING2-induced developmental
delay could be due to decreased expression of HDAC1
and concomitant increased expression of p21, and may
not be associated with apoptosis because there was
no increase in the expression of the pro-apoptotic Bax
transcripts (Fig. 4).
Discussion
In this study, we investigated the expression and
localization of ING2 during mouse preimplantation
development. We also demonstrated its physiological
function in embryonic development and made prelim-
inary investigations on its mechanism of action.
RT-PCR analysis revealed that there was a marked
increase in Ing2 expression from the 2-cell to 4-
cell embryo stage. This is consistent with the
immunostaining results, which showed an increase in
expression of ING2 at the protein level from the 2-
cell embryo stage, together with increasing localization
within the nucleus of 4-cell blastomeres. In mouse,
the first upsurge of gene expression occurs at the 2-
cell embryo stage, and is known as zygotic genome
activation (ZGA) (Flach et al., 1982; Latham et al., 1992;
Nothias et al., 1995). From then onwards, the embryo
will exploit its own transcriptional and translational
machinery to carry out its developmental program.
This enables reprogramming of the newly formed
embryonic genome to a totipotent state, which is
subsequently lost at the blastocyst stage (Duranthon
et al., 2008; Calle et al., 2012). Previous research
suggested that genes activated from the transition of
fertilized eggs to 4-cell embryos contribute mainly
to the regulation of basic cellular machinery, while
genes activated from transition of 8-cell embryos to
the morula and blastocyst stages are mainly associated
with dramatic biological and morphological events
(Hamatani et al., 2004). The spatio-temporal expression
pattern of ING2, may give some cues on how it may
contribute to mouse preimplantation development.
Further investigation showed that down-regulation
of ING2 by RNAi led to a decreased blastocyst
formation rate compared with the negative control
group, which means that ING2 does play a crucial role
in preimplantation development.
As a growth inhibition factor, ING2 has a PHD
domain that enables its interaction with H3K4Me3 to
regulate gene repression (Gozani et al., 2003; Shi et al.,
2006). ING2 is a stable component of the Sin3–HDAC
complex. It has been shown that ING2 negatively
regulates cell proliferation, chromatin remodeling,
apoptosis and DNA repair through modulation of the
p53 acetylation pathway, which incidentally enhance
its own transcription (Wang et al., 2006; Unoki et al.,
2008). Additionally, ING2 has also been implicated in
muscle differentiation through regulation of myogenin
transcription (Eapen et al., 2012). The tri-methylated
histone mark is found mainly in transcriptionally
active regions (Bannister & Kouzarides, 2004). ING2,
being a stable component of the Sin3–HDAC complex,
recruits and stabilizes the Sin3–HDAC complex on
gene promoters, leading to histone deacetylation and
gene repression (Doyon et al., 2006; Pena et al., 2006;
Shi et al., 2006). Histone deacetylase (HDAC) inhibitors
cause the dissociation of the PHD domain containing
ING2 subunit from the Sin3 deacetylase complex. The
loss of ING2 subsequently disrupts the in vivo binding
of the Sin3 complex to the p21 promoter (Smith et al.,
2010). In this study, we found that p21 expression was
significantly increased in ING2 knockdown embryos.
Additionally, there was dramatically decreased expres-
sion of HDAC1 in these ING2 knockdown embryos.
These results thus suggest that p21 as well as HDAC1
may contribute to the regulation of preimplantation
embryonic development. Previous studies show that
down-regulation of HDAC1 leads to hyperacetylation
of histone H4, which in turn results in developmental
delay. The underlying molecular mechanism involves
increased expression of p21, without any increase in
expression of either the pro-apoptotic Bax or Bcl2
transcripts within the HDAC1-depleted embryos (Ma
& Schultz, 2008). Additionally, induction of p21 was
also observed in Hdac1-deficient embryonic stem cells
(Lagger et al., 2002). In summary, this study has
demonstrated that ING2 plays important roles in
mouse preimplantation development which may be
associated with complex epigenetic mechanisms.
Nevertheless, it must be noted that although our
results do show that ING2 plays a crucial role in
preimplantation development, it is unlikely to be the
unique modulator of this process. As seen in Fig. 3C
and Table 1, only a certain percentage of embryos are
affected by microinjection of ING2-specific esiRNA.
This could suggest the existence of multiple redundant
signalling pathways in preimplantation development.
Indeed, it has been hypothesized that this redundancy
may provide a fail-safe protection to the preimplanta-
tion development programme (Kaye, 1997).
As a basic subunit of the Sin3–HDAC complex,
ING2 displays a high degree of interspecies homology
between human and mouse (Guerillon et al., 2013).
Hence, we hypothesize that ING2 may also play a
similar key role in human preimplantation embryonic
development. In clinical assisted reproduction, obtain-
ing high-quality embryos is critical for improving the
pregnancy rate. Additionally, extended culture and
transfer of embryos at the blastocyst stage for assisted
reproduction offers some theoretical advantages over
the transfer of cleavage-stage embryos. For example,
higher implantation rates, single embryo transfer and
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better temporal synchronization between embryo and
endometrium can be achieved by transfer of embryos
at the blastocyst stage (Jones et al., 1998; Tsirigotis,
1998; Hambiliki et al., 2013). However, the extended
duration of in vitro culture involves high risk of
reduction in the number of embryos available for
transfer, because the in vitro culture environment may
exert detrimental effects on embryonic development
(Jones et al., 1998; Kawamura et al., 2012; Calzi
et al., 2012). Hence rigorous characterization of the
regulatory mechanisms in embryonic development is
of great significance to clinical assisted reproduction.
This study sheds some light on the crucial role of ING2
in mouse preimplantation development which gives
an inkling on the function of ING2 in human in vitro
cultured embryos.
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